Tyra Biosciences, Inc.
USD28.66
-1.73 (-5.69%)
CEO
Todd Harris
IPO Date
2021-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$30.02
Prev. Close
$30.39
Day Low
$28.49
Day High
$30.02
52W Low
$8.98
52W High
$40.65
Market Cap
$1.70B
Volume
0.72M
| 13,160 |
| $32.68 |
| 1 Jun 2026 | Simson Jake | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | Gulfo Adele M. | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | MORE ROBERT J | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | Rothenberg Stephen Michael | director | A-Award | Acquired | 13,160 | $32.68 |
| 1 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 13,160 | $32.68 |
| 7 May 2026 | Warner Douglas J | Chief Medical Officer | A-Award | Acquired | 25,000 | $0.00 |
| 7 May 2026 | Warner Douglas J | Chief Medical Officer | A-Award | Acquired | 85,000 | $33.93 |
| 7 May 2026 | Fuhrman Alan | Chief Financial Officer | A-Award | Acquired | 20,000 | $0.00 |